Company Profile

Avenue Therapeutics is a specialty pharmaceutical company whose mission is to develop IV tramadol, a potential alternative that could reduce the use of conventional opioids, for patients suffering from acute pain in the U.S. Avenue is headquartered in New York City and was founded by Fortress Biotech, Inc.

Contact Information

Investor Relations
Jaclyn Jaffe and Bill Begien
T: 781-652-4500
ir@avenuetx.com

Company Contact
Avenue Therapeutics, Inc.
2 Gansevoort Street
9th Floor
New York, NY 10014